MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

Meeting: 2019 International Congress

Abstract Number: 1958

Keywords: Apathy, Parkinsonism, Positron emission tomography(PET)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To investigate the progression of dopaminergic and serotonergic dysfunction and their relation to motor and nonmotor impairment in parkinsonian patients with or without apathy, depression and anxiety

Background: De novo parkinsonian patients with apathy, depression and anxiety exhibit profound serotonergic dysfunction and microstructural disarray in the limbic system in comparison to non-apathetic patients, which supports distinct lesion profiles early in the disease although their progression is unknown.

Method: Fifteen apathetic (Lille Apathy Rating Scale (LARS) scores ≥ -21) and 15 non-apathetic parkinsonian patients were recruited at diagnosis and re-evaluated 3 to 5 years later in a two-group cohort study. In vivo PET imaging of the dopamine transporter (DAT) using [11C]-PE2I and the serotonin transporter (SERT) using [11C]-DASB was performed at baseline and repeated at follow-up. Longitudinal progression was assessed using linear mixed-effect models for clinical impairment and permutation-based inference for PET imaging.

Results: Eleven patients with apathy (PD-A) and 11 patients without apathy at diagnosis (PD-NA) completed the follow-up evaluation at median (IQR) 4.3 (0.6) years after diagnosis. Apathy, depression, anxiety and fatigue improved in PD-A patients over time, whereas these symptoms worsened in PD-NA patients (p<0.001). Besides neuropsychiatric symptoms, motor and other nonmotor (including somatic and sleep disorders) manifestations got worse as well as motor and nonmotor fluctuations in both groups. Striatal dopaminergic binding decreased bilaterally in both groups in the posterior and anterior putamen and caudate nucleus, and in the ventral tegmental area. Serotonin binding also decreased in both groups in the bilateral anterior putamen, medial thalamus, insula, right globus pallidus, left pulvinar, left subcallosal gyrus and bilateral dorsal raphe nucleus and ventral tegmental area, resulting in increased serotonin to dopamine transporters ratio in the posterior putamen bilaterally.

Conclusion: De novo parkinsonian patients with and without prominent apathy, depression and anxiety at diagnosis have distinct progression of neuropsychiatric burden over time and exhibit profound progression of striatal dopaminergic and limbic serotonergic dysfunction 3 to 5 years after diagnosis.

To cite this abstract in AMA style:

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois. Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/progression-of-dopaminergic-and-serotonergic-dysfunction-related-to-motor-and-nonmotor-manifestations-in-apathetic-and-non-apathetic-parkinsonian-patients-a-4-year-longitudinal-double-tracer-pet-stud/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/progression-of-dopaminergic-and-serotonergic-dysfunction-related-to-motor-and-nonmotor-manifestations-in-apathetic-and-non-apathetic-parkinsonian-patients-a-4-year-longitudinal-double-tracer-pet-stud/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley